First‐in‐Human Study of Merotocin, a Short‐Acting Peptidic Oxytocin Receptor Agonist for Lactation Support

Documenti analoghi

• Effect of Hepatic and Renal Impairment on the Pharmacokinetics of Dersimelagon (MT‐7117), an Oral Melanocortin‐1 Receptor Agonist
  di: Akihito Ogasawara, et al.
  Pubblicazione: (2024)
• Integrating Pharmacogenomic Insights in GLP‐1 Receptor Agonist Therapy: Direct GLP1R and ARRB1 Variants and Indirect CYP2D6 Influences in Personalized Obesity Management
  di: Navodi Sandamini Jayathilaka, et al.
  Pubblicazione: (2025)
• Strategies to Manage Dosing Deviations and Interruptions of Cabotegravir Long‐Acting Intramuscular Injections
  di: Kelong Han, et al.
  Pubblicazione: (2025)
• The Work Behind the First Dose: How Early Clinical Studies Shape the Course of Drug Development
  di: Amalia M. Issa
  Pubblicazione: (2026)
• A Randomized Phase 1 Study Evaluating Pharmacokinetics, Safety, and Tolerability of a High‐Concentration, Long‐Acting Cabotegravir Formulation in Adults Without HIV
  di: Kelong Han, et al.
  Pubblicazione: (2025)